传奇生物
LEGN
18.48
-1.32
-6.67%
传奇生物
US · LEGN
#2374 按市值排名
上市于 2020
18.48
-1.32
-6.67%
实时 - 追踪5344个代码 - 心跳于556秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了4家。
- 机构持股总比例下降了0.8个百分点。
机构持股
- 机构持股比例
- 53.85% -0.85pp
- 机构数量
- 274 -4
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund30.61%
Hedge Fund16.51%
VC/PE Fund3.51%
Public Company2.61%
Private Company0.39%
Government Pension Fund0.12%
Individual/Insider0.12%
Other46.04%
主要股东 截至 2026-06-30
FMR
14.80% · 28.68M 股
Deerfield Management Company, L.P.
4.20% · 8.14M 股
Montanova Capital, LLC
3.65% · 7.07M 股
Hillhouse Capital Management, Ltd.
3.09% · 5.98M 股
BlackRock
2.44% · 4.73M 股
Westfield Capital Management Company, L.P.
2.29% · 4.43M 股
The Goldman Sachs Group, Inc.
1.88% · 3.63M 股
Point72 Asset Management, L.P.
1.59% · 3.08M 股
Kynam Capital Management, LP
1.55% · 3.00M 股
Assenagon Asset Management S.A.
0.99% · 1.92M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 0次买入 · 42次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Ying Huang | Chief Executive Officer | 0.06% |
| Xiaohui Ji | Independent Director | 0.01% |
| Patrick Casey | Independent Director | 0.01% |
| Li Mao | Independent Director | 0.01% |
| Tomas Heyman | Independent Director | 0.01% |
| Corazon Sanders | Independent Director | 0.01% |
| Gareth Kung | Director | -- |
| Jessie Yeung | Former Head of Corporate Finance & Investor Relations | -- |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-03-25 | Ying Huang | Chief Executive Officer | Intent to Sell (Form 144) | -4,968 | $17.54 |
| 2026-03-25 | Jessie Yeung | Former Head of Corporate Finance & Investor Relations | Intent to Sell (Form 144) | -1,862 | $17.54 |
| 2026-03-17 | Corazon Sanders | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Ying Huang | Chief Executive Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Gareth Kung | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Xiaohui Ji | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Tomas Heyman | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Patrick Casey | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Li Mao | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2025-12-25 | Ying Huang | Chief Executive Officer | Intent to Sell (Form 144) | -64,339 | $22.52 |
| 2025-12-23 | Corazon Sanders | Independent Director | Intent to Sell (Form 144) | -969 | $22.77 |
| 2025-12-23 | Ying Huang | Chief Executive Officer | Intent to Sell (Form 144) | -61,467 | $22.95 |
| 2025-11-16 | GenScript Corporation | -- | Intent to Sell (Form 144) | -203,586 | $30.29 |
| 2025-09-25 | Patrick Casey | Independent Director | Intent to Sell (Form 144) | -1,000 | $33.29 |
| 2025-09-23 | Ying Huang | Chief Executive Officer | Intent to Sell (Form 144) | -1,370 | $33.00 |
| 2025-09-22 | Corazon Sanders | Independent Director | Intent to Sell (Form 144) | -307 | $34.00 |
| 2025-09-22 | Ying Huang | Chief Executive Officer | Intent to Sell (Form 144) | -1,357 | $33.98 |
| 2025-09-22 | Jessie Yeung | Former Head of Corporate Finance & Investor Relations | Intent to Sell (Form 144) | -474 | $33.98 |
| 2025-07-22 | Ying Huang | Chief Executive Officer | Intent to Sell (Form 144) | -15,291 | $45.04 |
| 2025-06-25 | Patrick Casey | Independent Director | Intent to Sell (Form 144) | -1,000 | $33.23 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:28 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
传奇生物 讨论区 0 条评论